Annual Total Liabilities
$38.93 M
+$5.57 M+16.70%
December 31, 2023
Summary
- As of February 23, 2025, SEEL annual total liabilities is $38.93 million, with the most recent change of +$5.57 million (+16.70%) on December 31, 2023.
- During the last 3 years, SEEL annual total liabilities has risen by +$24.01 million (+160.88%).
Performance
SEEL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$30.51 M
-$6.20 M-16.89%
June 30, 2024
Summary
- As of February 23, 2025, SEEL quarterly total liabilities is $30.51 million, with the most recent change of -$6.20 million (-16.89%) on June 30, 2024.
- Over the past year, SEEL quarterly total liabilities has dropped by -$6.12 million (-16.70%).
Performance
SEEL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SEEL Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +16.7% | -16.7% |
3 y3 years | +160.9% | -8.5% |
5 y5 years | +3176.8% | +471.4% |
SEEL Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -32.8% | -48.3% | -17.9% |
5 y | 5-year | at high | -71.5% | -48.3% | -89.6% |
alltime | all time | at high | -98.2% | -48.3% | -99.0% |
Seelos Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $30.51 M(-16.9%) |
Mar 2024 | - | $36.72 M(-5.7%) |
Dec 2023 | $38.93 M(+16.7%) | $38.93 M(+6.3%) |
Sep 2023 | - | $36.63 M(-38.0%) |
Jun 2023 | - | $59.07 M(+33.3%) |
Mar 2023 | - | $44.30 M(+32.8%) |
Dec 2022 | $33.36 M(+27.4%) | $33.36 M(+2.2%) |
Sep 2022 | - | $32.63 M(+23.4%) |
Jun 2022 | - | $26.44 M(+5.5%) |
Mar 2022 | - | $25.06 M(-4.3%) |
Dec 2021 | $26.18 M(+75.4%) | $26.18 M(+225.8%) |
Sep 2021 | - | $8.03 M(+5.6%) |
Jun 2021 | - | $7.61 M(-54.2%) |
Mar 2021 | - | $16.61 M(+11.3%) |
Dec 2020 | $14.92 M(+34.4%) | $14.92 M(+368.4%) |
Sep 2020 | - | $3.19 M(-21.4%) |
Jun 2020 | - | $4.05 M(-45.3%) |
Mar 2020 | - | $7.41 M(-33.3%) |
Dec 2019 | $11.10 M(+834.6%) | $11.10 M(+89.4%) |
Sep 2019 | - | $5.86 M(+9.8%) |
Jun 2019 | - | $5.34 M(-42.6%) |
Mar 2019 | - | $9.31 M(+683.4%) |
Dec 2018 | $1.19 M(-49.1%) | $1.19 M(-18.1%) |
Sep 2018 | - | $1.45 M(-25.1%) |
Jun 2018 | - | $1.94 M(+11.9%) |
Mar 2018 | - | $1.73 M(-25.8%) |
Dec 2017 | $2.33 M(-80.9%) | $2.33 M(-6.7%) |
Sep 2017 | - | $2.50 M(+11.6%) |
Jun 2017 | - | $2.24 M(-50.3%) |
Mar 2017 | - | $4.51 M(-63.1%) |
Dec 2016 | $12.22 M(-31.1%) | $12.22 M(-23.4%) |
Sep 2016 | - | $15.95 M(+2.2%) |
Jun 2016 | - | $15.61 M(-9.7%) |
Mar 2016 | - | $17.27 M(-2.5%) |
Dec 2015 | $17.73 M(+37.5%) | $17.73 M(+1.2%) |
Sep 2015 | - | $17.51 M(+19.6%) |
Jun 2015 | - | $14.64 M(-18.5%) |
Mar 2015 | - | $17.97 M(+39.4%) |
Dec 2014 | $12.89 M(+4.5%) | $12.89 M(+65.3%) |
Sep 2014 | - | $7.80 M(-7.6%) |
Jun 2014 | - | $8.44 M(-47.6%) |
Mar 2014 | - | $16.10 M(+30.5%) |
Dec 2013 | $12.34 M(-28.5%) | $12.34 M(+19.2%) |
Sep 2013 | - | $10.35 M(-23.5%) |
Jun 2013 | - | $13.53 M(-21.5%) |
Mar 2013 | - | $17.24 M(-0.1%) |
Dec 2012 | $17.26 M(+46.3%) | $17.26 M(+0.3%) |
Sep 2012 | - | $17.21 M(+39.3%) |
Jun 2012 | - | $12.36 M(+5.6%) |
Mar 2012 | - | $11.70 M(-0.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $11.80 M(+61.7%) | $11.80 M(+53.2%) |
Sep 2011 | - | $7.70 M(-9.5%) |
Jun 2011 | - | $8.51 M(+13.6%) |
Mar 2011 | - | $7.49 M(+2.7%) |
Dec 2010 | $7.30 M(-60.0%) | $7.30 M(+6.3%) |
Sep 2010 | - | $6.87 M(-6.8%) |
Jun 2010 | - | $7.37 M(-56.8%) |
Mar 2010 | - | $17.05 M(-6.4%) |
Dec 2009 | $18.23 M(+159.5%) | $18.23 M(+263.5%) |
Sep 2009 | - | $5.01 M(-21.0%) |
Jun 2009 | - | $6.35 M(-4.7%) |
Mar 2009 | - | $6.66 M(-5.2%) |
Dec 2008 | $7.03 M(+19.7%) | $7.03 M(-14.4%) |
Sep 2008 | - | $8.21 M(+5.8%) |
Jun 2008 | - | $7.76 M(+31.1%) |
Mar 2008 | - | $5.92 M(+0.9%) |
Dec 2007 | $5.87 M(-30.4%) | $5.87 M(+26.2%) |
Sep 2007 | - | $4.65 M(-1.5%) |
Jun 2007 | - | $4.72 M(-42.5%) |
Mar 2007 | - | $8.21 M(-2.6%) |
Dec 2006 | $8.43 M(-33.6%) | $8.43 M(-14.8%) |
Sep 2006 | - | $9.90 M(-1.1%) |
Jun 2006 | - | $10.01 M(-9.0%) |
Mar 2006 | - | $11.00 M(-13.4%) |
Dec 2005 | $12.69 M(+43.1%) | $12.69 M(-10.3%) |
Sep 2005 | - | $14.15 M(+19.7%) |
Jun 2005 | - | $11.82 M(+38.3%) |
Mar 2005 | - | $8.55 M(-3.7%) |
Dec 2004 | $8.87 M(-14.8%) | $8.87 M(-4.1%) |
Sep 2004 | - | $9.25 M(-11.8%) |
Jun 2004 | - | $10.49 M(+2.0%) |
Mar 2004 | - | $10.28 M(-1.3%) |
Dec 2003 | $10.41 M(-4.6%) | $10.41 M(+147.8%) |
Sep 2003 | - | $4.20 M(-28.2%) |
Jun 2003 | - | $5.85 M(-38.4%) |
Mar 2003 | - | $9.49 M(-13.1%) |
Dec 2002 | $10.92 M(+240.4%) | $10.92 M(+53.8%) |
Sep 2002 | - | $7.10 M(-5.5%) |
Jun 2002 | - | $7.51 M(+181.0%) |
Mar 2002 | - | $2.67 M(-16.6%) |
Dec 2001 | $3.21 M(+157.5%) | $3.21 M(+63.3%) |
Sep 2001 | - | $1.96 M(+77.7%) |
Jun 2001 | - | $1.11 M(-14.1%) |
Mar 2001 | - | $1.29 M(+3.3%) |
Dec 2000 | $1.25 M(+77.9%) | $1.25 M(+159.7%) |
Sep 2000 | - | $479.60 K(+50.7%) |
Jun 2000 | - | $318.20 K(-24.7%) |
Mar 2000 | - | $422.80 K |
Dec 1999 | $700.00 K(-91.6%) | - |
Dec 1998 | $8.32 M(+155.1%) | - |
Dec 1997 | $3.26 M | - |
FAQ
- What is Seelos Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Seelos Therapeutics?
- What is Seelos Therapeutics annual total liabilities year-on-year change?
- What is Seelos Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly total liabilities year-on-year change?
What is Seelos Therapeutics annual total liabilities?
The current annual total liabilities of SEEL is $38.93 M
What is the all time high annual total liabilities for Seelos Therapeutics?
Seelos Therapeutics all-time high annual total liabilities is $38.93 M
What is Seelos Therapeutics annual total liabilities year-on-year change?
Over the past year, SEEL annual total liabilities has changed by +$5.57 M (+16.70%)
What is Seelos Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SEEL is $30.51 M
What is the all time high quarterly total liabilities for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly total liabilities is $59.07 M
What is Seelos Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SEEL quarterly total liabilities has changed by -$6.12 M (-16.70%)